Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home > Pharma China Web Edition    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905
Email:
info@pharmachinaonline.com

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Email:
info@pharmachinaonline.com
 
 
 
News
 
NCCD, Lilly China Enter Collaboration for CVD Research 4/24/2018
30 Listed Chinese Pharma Cos Spent Over CNY 1B on Sales & Mar... 4/24/2018
Chinese PD Hospital Drug Market on Steady Growth of 10% CAGR 2013... 4/24/2018
CPA Releases Topline Data of 2017 Hospital Drug Purchase Audit 4/24/2018
China Announces Import Tariff Reduction of Some Drugs including A... 4/24/2018
CNDA Issues Announcement over Matters Related to Import of APIs a... 4/24/2018
1/3 of Listed Chinese Pharma Cos Invested Over CNY 100M into R&am... 4/24/2018
EpimAb and Zhejiang Teruisi Biopharma to Co-develop FIT012 Bispec... 4/24/2018
CBT and CrystalGenomics Announce Partnership to Co-develop I/O Th... 4/24/2018
Merck Group Receives Patent for CRISPR Technology in China 4/24/2018
Simcere, Hitgen Enter Partnership and License for New Drug Discov... 4/24/2018
More>>
 
Feature Articles
 
Gibson: U.S.'s Growing Dependence on China For Vital Medicines A ... 4/24/2018
PharmExec: Biosimilars in China 4/24/2018
Breaking News on New Policies of Innovative Drugs in China 4/19/2018
Chinese Money Floods U.S. Biotech as Beijing Chases New Cures 4/18/2018
China Announces New Initiatives to Level the Playing Field for In... 4/18/2018
U.S. Businesses Worried over Chinese Policy Initiative 4/17/2018
China Will Always Be Bad at Bioethics 4/17/2018
Why Immuno-Therapy Is Leaving Markets Abuzz Across the World 4/17/2018
Goldman Sachs: China Is Beating the U.S. in the Gene Editing Arms... 4/17/2018
Bloomburg: China Is Nationalizing Its Tech Sector 4/12/2018
PharmExec: China's CAR-T Therapy Race 4/10/2018
More>>
 
 
 
 
© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links